Skip to main content
Clinical Trials/NCT03020654
NCT03020654
Unknown
N/A

The Use of Virtual Reality for the Treatment of Visual Vertigo.

Sheffield Teaching Hospitals NHS Foundation Trust1 site in 1 country18 target enrollmentJanuary 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Treatment of Visual Vertigo
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Enrollment
18
Locations
1
Primary Endpoint
Change in scoring on the Situational Characteristic Questionnaire
Last Updated
8 years ago

Overview

Brief Summary

This study investigates the use of virtual environments presented on a head mounted display for the rehabilitation of those suffering with visual vertigo.

The control group and treatment groups will be presented with two different sets of environments and be given the same head and eye exercises to complete within the environment. They will also be provided with at home exercises to complete.

Detailed Description

Visual vertigo occurs after the balance system suffers damage (e.g after a viral infection such as labyrinthitis). This causes an over-reliance on the eyes to maintain balance which causes disorientation in busy environments such as the supermarket. The treatment involves trying to desensitise the individual to visually stimulating situations. Further head and eye exercises are completed alongside the exposure to overcome the damage done to the balance system.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
November 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Those who have been diagnosed with visual vertigo and have scored a significant level on the Situational Characteristic Questionnaire (over 0.74 as per Pavlou et al., 2006).

Exclusion Criteria

  • Those with or under investigation for epilepsy.
  • Those who have been determined to have no or limited balance function in both ears.
  • Those with reduced visual acuity that will leave them unable to view the 3D effects of the head mounted display.
  • Those with severe mental health disorders e.g. psychosis, paranoid disorders, bipolar disorder or a history of substance abuse.
  • Severe neck pain/ restricted movement.
  • Previous treatment for visual vertigo.
  • Those with an fluctuating vestibular disorder such as Ménière's disease or vestibular migraine.
  • Those with untreated Benign Paroxymal Positional Vertigo (BPPV).
  • Those with a significant brain injury, or head injury that results in a central vestibular disorder.
  • Those with an arrhythmia.

Outcomes

Primary Outcomes

Change in scoring on the Situational Characteristic Questionnaire

Time Frame: Week 1 and Week 6

A measure of visual vertigo symptom level

Secondary Outcomes

  • Change in scoring on the PHQ-9 Questionnaire from week one to six(Week 1 and Week 6)
  • Change in scoring on the GAD-7 Questionnaire from week one to six(Week 1 and Week 6)

Study Sites (1)

Loading locations...

Similar Trials